BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38149007)

  • 21. [Correlations Between Gut Microbiota Changes and Cognitive Function in Patients with Post-Stroke Cognitive Impairment in the Early Stage].
    Li YM; Yu Q; Huang L; Fu J; Feng RJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):857-865. PubMed ID: 36224689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens.
    Frost F; Weiss FU; Sendler M; Kacprowski T; Rühlemann M; Bang C; Franke A; Völker U; Völzke H; Lamprecht G; Mayerle J; Aghdassi AA; Homuth G; Lerch MM
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00232. PubMed ID: 33094959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune Gene Expression Covaries with Gut Microbiome Composition in Stickleback.
    Fuess LE; den Haan S; Ling F; Weber JN; Steinel NC; Bolnick DI
    mBio; 2021 May; 12(3):. PubMed ID: 33947750
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Marra A; Hanson MA; Kondo S; Erkosar B; Lemaitre B
    mBio; 2021 Aug; 12(4):e0082421. PubMed ID: 34253067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic defense.
    Dunn KA; MacDonald T; Rodrigues GJ; Forbrigger Z; Bielawski JP; Langille MGI; Van Limbergen J; Kulkarni K
    Front Cell Infect Microbiol; 2022; 12():924707. PubMed ID: 35967843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.
    Lin Z; Mao D; Jin C; Wang J; Lai Y; Zhang Y; Zhou M; Ge Q; Zhang P; Sun Y; Xu K; Wang Y; Zhu H; Lai B; Wu H; Mu Q; Ouyang G; Sheng L
    Front Immunol; 2023; 14():1105293. PubMed ID: 36891300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19.
    Trøseid M; Holter JC; Holm K; Vestad B; Sazonova T; Granerud BK; Dyrhol-Riise AM; Holten AR; Tonby K; Kildal AB; Heggelund L; Tveita A; Bøe S; Müller KE; Jenum S; Hov JR; Ueland T;
    Crit Care; 2023 Feb; 27(1):69. PubMed ID: 36814280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma.
    Huo R; Chen Y; Li J; Xu Q; Guo J; Xu H; You Y; Zheng C; Chen Y
    Curr Oncol; 2023 Feb; 30(2):1818-1830. PubMed ID: 36826102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robust cross-cohort gut microbiome associations with COVID-19 severity.
    Li J; Ghosh TS; McCann R; Mallon P; Hill C; Draper L; Schult D; Fanning LJ; Shannon R; Sadlier C; Horgan M; O'Mahony L; O'Toole PW
    Gut Microbes; 2023; 15(1):2242615. PubMed ID: 37550964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity.
    Harding JN; Siefker D; Vu L; You D; DeVincenzo J; Pierre JF; Cormier SA
    BMC Microbiol; 2020 Jun; 20(1):140. PubMed ID: 32487019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
    Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J
    J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome.
    Brīvība M; Silamiķele L; Birzniece L; Ansone L; Megnis K; Silamiķelis I; Pelcmane L; Borisova D; Rozenberga M; Jagare L; Elbere I; Kloviņš J
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
    Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
    J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the Lipid Profile, Type 2 Diabetes and Medication on the Metabolic Syndrome-Associated Gut Microbiome.
    Gradisteanu Pircalabioru G; Liaw J; Gundogdu O; Corcionivoschi N; Ilie I; Oprea L; Musat M; Chifiriuc MC
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
    Shi Z; Qiu Y; Wang J; Fang Y; Zhang Y; Chen H; Du Q; Zhao Z; Yan C; Yang M; Zhou H
    J Neuroimmunol; 2020 Feb; 339():577126. PubMed ID: 31841737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut.
    Zeng X; Gao X; Peng Y; Wu Q; Zhu J; Tan C; Xia G; You C; Xu R; Pan S; Zhou H; He Y; Yin J
    Front Cell Infect Microbiol; 2019; 9():4. PubMed ID: 30778376
    [No Abstract]   [Full Text] [Related]  

  • 40. Gut microbiota on admission as predictive biomarker for acute necrotizing pancreatitis.
    Zou M; Yang Z; Fan Y; Gong L; Han Z; Ji L; Hu X; Wu D
    Front Immunol; 2022; 13():988326. PubMed ID: 36105818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.